Podcasts about Intra

Investors often believe that when markets “recover,” their portfolios do too — but that's a dangerous illusion. In this episode, Lance Roberts breaks down why percentage losses and gains are not symmetrical, and how a 50% loss requires a 100% gain just to break even. We'll discuss why bear market math destroys long-term returns, how emotional investors get trapped in the “illusion of recovery,” and why managing risk during drawdowns matters more than chasing every rally. 0:19 - The First Full Trading Week of October - Action 4:11 - Markets - Overbought & Overconfident? 9:27 - Where is the Promised Recession? 12:06 - What is Supporting the Market? 15:53 - The Overall Liquidity Base is Still Flush 19:19 - Annual vs Intra-year Returns Comparison 22:18 - Understanding Losses in Bear Markets - not symmetrical 27:02 - The Math of Loss 29:32 - The Importance of Understanding the Difference Between Points & Percentages 33:49 - Why Markets Do Not Compound 34:19 - The Function of Time on Investments 39:26 - Six Strategies That Work When Markets Don't 46:48 - Preview: Trading Guide Rules from Master Investors

Kenan a grandi dans sa famille paternelle, où les violences intra-familiales étaient quotidiennes. À l'âge de 9 ans, son cousin abuse de lui et son père l'empêche de parler, afin de ne pas ternir la réputation de la famille. Aujourd'hui, Kenan brise le silence, témoigne et sensibilise à travers son livre, mais également au sein d'associations. Hébergé par Audion. Visitez https://www.audion.fm/fr/privacy-policy pour plus d'informations.

The benchmark US equity indices booked another round of fresh record intra-day and closing highs to open the week - Dow edged +66-points or +0.14% to 46,381.54. Apple Inc rallied +4.31% to be the leading performer in the 30-stock index following reports of strong demand for the iPhone 17 in its first weekend of sales, aided by consumers seeking to replace aging devices. The stock is closing in on a fresh record closing high (after touching their highest intra-day level since December 2024 overnight at US$256.64) and market capitalisation of US$4 trillion. ‘Magnificent Seven' mega-capitalisation technology peer Nvidia Corp rallied +3.93% to a record closing high of US$183.61 after the company said it's going to invest US$100B in OpenAI - the maker of ChatGPT - for the buildout of data centres based around the company's artificial intelligence (AI) chips. The partnership "enables OpenAI to build and deploy at least 10 gigawatts of AI data centres with NVIDIA systems representing millions of GPUs [graphics processing unit] for OpenAI's next-generation AI infrastructure." Nvidia added it "intends to invest up to US$100B in OpenAI progressively as each gigawatt is deployed." However, Amazon.com Inc fell -1.66% as investors assessed the potential fallout from President Trump's shock decision late on Friday (19 September) to raise the H-1B visa application fee to US$100,000. Amazon employs ~14K staff on such visas.

Both the S&P 500 and Nasdaq hit fresh record intra-day and closing highs ahead of the Federal Reserve's latest two-day monetary policy meeting kicking off that is expected to see the central bank cut benchmark interest rates for the first time this year - Dow edged +49-points or +0.11% higher, with so-called ‘Magnificent Seven' mega-capitalisation technology names Amazon.com Inc (up +1.44%), Apple Inc (+1.12%) and Microsoft Corp (+1.07%) rising over >1% along with Caterpillar Inc (+1.02%) and International Business Machines (IBM) Corp (+1.10%). Merck & Co Inc (-1.20%) and McDonald's Corp (-1.09%) fell over >1% to be the worst performing Dow components overnight. Nvidia Corp dipped -0.04%, paring an earlier decline of almost -1.9% after China's State Administration for Market Regulation (SAMR) announced that following a preliminary investigation the chip giant was found to be in breach of antitrust rules in relation to its acquisition of Israel-based networking-technology group Mellanox. Separately, Nvidia is reportedly among investors in artificial intelligence (AI) infrastructure company Firmus Technologies, which is targeting a listing on the Australian Securities Exchange (ASX) next year.  

This month sustainability focused, Japan based consultants, educators and entrepreneurs Tove Kinooka and JJWalsh discuss Sustainable Japan Day event and awards featured by the Japan Times ⁨@thejapantimes⁩ - One Young World - Sustainability in the Himalaya mountains with Carole Fuchs - Tech for Impact event in Tokyo October - Global Perspectives workshops and INTRApreneurship training programs - Digital Collage September event ICHIGO BLOOM - Responsible Finance and Investing with Morisawa Michiyo - Wooden Barrels Craft Award Yamaroku Shoyu Shodoshima - Made-in-Japan apparel - Sustainable Forestry in Wakayama - Zero-Carbon baseball stadium HANSHIN Tigers - GLIN impact capital investments in startups with social and environmental impact - Outrage & Optimism podcast ⁨@OutrageandOptimism⁩ - HGPI Health and Environment intersection - Yamaroku Soy Sauce - Yamagata rural revival ..LINKS- Sustainable Japan day event 2025 on September 18 https://sustainable.japantimes.com/sjd-2025 - UNICHARM circularity in diaper business for babies and elderly - recycled pulp & recycle used https://www.unicharm.co.jp/en/csr-eco/education.html - One Young World https://www.oneyoungworld.com/ ⁨@OneYoungWorld⁩ - Global Perspectives workshops & Intra-preneurship training https://www.globalperspectives.biz/intrapreneurship- Tech 4 Impact Summit https://tech4impactsummit.com/- Digital Collage event in Sept 2025 Ichigo Bloom Tokyo https://ichigobloom.jp/digital-collage-explore-the-hidden-footprint-of-our-digital-lives-tokyo-21-september-2025/- Morisawa Michiyo feature about Responsible Investing https://sustainable.japantimes.com/unraveling/25- Yamaroku Shoyu SHODOSHIMA island https://yama-roku.net/en- Factelier made-in-japan clothing apparel https://factelier.com/aboutus/- WAKAYAMA sustainable forestry https://nakagawa-forestry.com/about- Hanshin Tigers Zero Carbon Baseball Stadium https://zerocarbon-bp.hanshin.co.jp/park/map.html- GLIN social and environmental impact funding, startups and investing https://glinimpact.com/en/insight/insight-investment20231017- Japan Health and Environmental policy intersection advising and diplomacy https://hgpi.org/en/- Netchu Rural Revitalization in Yamagata - reusing abandoned schools to...

https://x.com/DrDaniS/status/1960716937518100974  @thehappywifeschool  The Surprising Secrets Your Wife Holds About Sex | The Happy Wife School Show Ep. 76 https://www.youtube.com/live/ZXnj36wZmqY?si=NWL1xujOX3zzt-0c  @OrthodoxEthos  Honoring God In Sexual Relations — According to St. Porphyrios https://youtu.be/BjJI6SL4B6g?si=-__gRsfV2kZHfq6F https://www.drpsychmom.com/author/samrodman/  https://www.drpsychmom.com/what-men-think-about-sex-versus-reality/ https://www.drpsychmom.com/women-sex-vs-reality/ Why is the Church Today so Sex Positive when the Ancient Church was so Sex Negative? Livestream! https://www.youtube.com/live/DaaDihjp0gM?si=wvdPQ1WMYCx5AkpC Why is the Church Today so Sex Positive when the Ancient Church was so Sex Negative? https://youtu.be/vmq-AcRN9DY?si=KuA2ydCu9GjwWkkA Fertility Suppression by Elite Women. What is the Source of this Assault on Humanity's Future? https://youtu.be/wu56e0Ds9wo  @BenjaminABoyce  Female Psychology & The End of Empires | with Dr. Dani Sulikowski https://youtu.be/sRY_1JRRcNU?si=A3C5vu73PEu4t83J   @radicalhealthradio  Reacting to Aubrey Marcus Polyamory (“Radical Monogamy”) https://youtu.be/Vas3iUub4SY?si=c4WJMEqCgx9RYHcW  @AubreyMarcusPod  An Evolution of Sacred Union | Vylana, Alana Beale, Dr. Marc Gafni https://youtu.be/q_4_WD6-9MI?si=XHogGN-Ue2m6doh3 https://www.southeastuary.com/ https://www.southeastuary.com/ https://www.livingstonescrc.com/give Paul Vander Klay clips channel https://www.youtube.com/channel/UCX0jIcadtoxELSwehCh5QTg https://www.meetup.com/sacramento-estuary/ My Substack https://paulvanderklay.substack.com/ Bridges of meaning https://discord.gg/cfwxQ96Q Estuary Hub Link https://www.estuaryhub.com/ If you want to schedule a one-on-one conversation check here. https://calendly.com/paulvanderklay/one2one There is a video version of this podcast on YouTube at http://www.youtube.com/paulvanderklay To listen to this on ITunes https://itunes.apple.com/us/podcast/paul-vanderklays-podcast/id1394314333  If you need the RSS feed for your podcast player https://paulvanderklay.podbean.com/feed/  All Amazon links here are part of the Amazon Affiliate Program. Amazon pays me a small commission at no additional cost to you if you buy through one of the product links here. This is is one (free to you) way to support my videos.  https://paypal.me/paulvanderklay Blockchain backup on Lbry https://odysee.com/@paulvanderklay https://www.patreon.com/paulvanderklay Paul's Church Content at Living Stones Channel https://www.youtube.com/channel/UCh7bdktIALZ9Nq41oVCvW-A To support Paul's work by supporting his church give here. https://tithe.ly/give?c=2160640 https://www.livingstonescrc.com/give  

Discover why intra-Africa trade is extremely crucial for promoting economies, leveraging the continent's vast resources (population, arable land), and scaling up economic growth. We tackle the challenges faced by small producers in accessing export markets due to structural constraints, costly undertakings, and infrastructure gaps. The series calls for the removal of red tape, significant investment in physical and digital infrastructure, stable regulatory frameworks, and addressing corruption to attract investors and foster seamless trade within the continent. This episode underscores the powerful truth that "trade is better than aid" for empowering communities and building a thriving, ethical, and sustainable future for Africa. We also highlight the importance of succession planning and supporting the youth in agriculture, alongside the rapid implementation of initiatives like the African Continental Free Trade Agreement (AfCFTA).

In this gripping episode, we welcome back frequent guest and forensic mental health expert Dr. Jerrod Brown to explore the devastating phenomenon of intra-familial homicide—when murder occurs within the home, at the hands of someone trusted and loved. From uxoricide (husbands killing wives) to parricide (children murdering parents), these crimes tear at the fabric of our social and emotional understanding. Why do they happen? How can we spot the warning signs? And what role does neurocriminology play in helping us make sense of the unthinkable?

The Nasdaq 100 fell as much as 1.5% before recovering to close just 0.6% lower. Markets remain on edge ahead of key events, including Jay Powell's speech at the Jackson Hole Symposium tomorrow, whilst the USD remains unchanged and gold rises amid concerns over Fed independence. UK inflation surged to an 18-month high and government bonds rallied, lifting large-cap UK stocks, whilst Asian markets showed mixed results, with technology-heavy Korea and Taiwan rising and Japan's Nikkei 225 falling. Shares in Shanghai have reached their highest in a decade. Carsten Menke, Head of Next Generation Research, discusses the Circular Economy investment theme, focusing on the plastic problem.(00:00) - Introduction: Helen Freer, Product & Investment Content (00:28) - Markets wrap-up: Mike Rauber, Product & Investment Content (06:34) - Circular Economy: Carsten Menke, Head of Next Generation Research (10:26) - Closing remarks: Helen Freer, Product & Investment Content Would you like to support this show? Please leave us a review and star rating on Apple Podcasts, Spotify or wherever you get your podcasts.

In this episode, Dr. Sergio Zanotti discusses ECPR–Extracorporeal Cardiopulmonary Resuscitation. ECPR is still be considered a niche therapy, but its relevance and availability are increasing. He is joined by Dr. Adam Green, a practicing intensivist at Cooper University Health Care and an Associate Professor of Medicine at Cooper Medical School of Rowan University (CMSRU). Dr. Green is the director of research for the division of Critical Care and has authored over 50 peer-reviewed publications. He has been part of the ECMO team at Cooper since its inception. Additional resources: Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest. The Lancet Respiratory Medicine 2025: https://www.sciencedirect.com/science/article/pii/S2213260025001225 Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest. JAMA 2022: https://jamanetwork.com/journals/jama/fullarticle/2789313 Association between increasing institutional experience with ECPR and outcomes in patients with out-of-hospital cardiac arrest: A nationwide multicenter observational study in Japan (the JAAM–OHCA registry) RESUSCITATION 2025: https://www.resuscitationjournal.com/article/S0300-9572(24)00862-1/fulltext Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest. N Eng J of Med 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2204511 Books mentioned in this episode: The Perfect Predator: A Scientist's Race to Save Her Husband from a Deadly Superbug. By S. Strathdee and T Patterson: https://amzn.to/3Hxjmez

Robert Yang is a leading expert in digestive wellness, hormone restoration, and performance nutrition with over 27 years of clinical experience. He is an internationally sought-after presenter on a variety of topics on nutrition, gut health, and performance enhancement. He serves as an advisory board member for Titleist Performance Institute, the National Pitching Association, and the USDA's US National Development Program, where he's also the team nutritionist. He consults with elite professional athletes from the XGames, NFL, NHL, MLB, AVP, PGA, LPGA, and European Tour. In this episode of Conversations for Health, we examine the intersection of sports performance and functional nutrition, focusing on both elite and developing athletes. If you work with kids and their parents, you will find this conversation exceptionally valuable. Robert generously shares clinical pearls, information about the labs that he uses with athletes, pre- and post-workout nutrition, traumatic brain injuries, and much more, including the big picture that parents, coaches, and healthcare practitioners need to understand about long-term athletic development for youth athletes.   I'm your host, Evelyne Lambrecht. Thank you for designing a well world with us.   Episode Resources: Robert Yang: robertyang.net Design for Health Resources: Designs for Health - https://www.designsforhealth.com/ Designs for Health Practitioner Exclusive Drug Nutrient Depletion and Interaction Checker - https://www.designsforhealth.com/drug-nutrient-interaction/ Visit the Designs for Health Research and Education Library, which houses medical journals, protocols, webinars, and our blog. https://www.designsforhealth.com/research-and-education/education The Designs for Health Podcast is produced in partnership with Podfly Productions. Chapters: 00:00 Intro. 02:49 Robert Yang's career focuses on sports and performance nutrition and working with elite associations and athletes. 05:54 Key points of long-term athletic development and training for youth.  10:15 Training youth athletes fast throughout growth spurts. 18:07 A foundation of hydration and sodium in training athletes. 24:00 Protein recommendations during training and growth spurts. 29:24 Protein, fat, and fiber for blood sugar control. 30:34 Athletes, GI issues, leaky gut, and inflammation markers. 34:54 Dr. Yang's approach to anti-inflammatories, NSAIDs, and nutrients. 38:33 Lab panels for iron deficiencies and excess storage iron. 41:28 Creatine, amino acid, and other preferred supplements for pre- and post-workout. 49:02 Robert's nutrition strategy and views on intermittent fasting. 56:39 Intra-workout strategies for aging and average patients. 59:25 Post-workout carbohydrates and protein ratio recommendations. 1:04:30 Adaptogens, essential fatty acids, fish oil, and Omega-3 index numbers. 1:10:40 Nutrient recommendations for addressing traumatic brain injuries. 1:17:49 Robert's favorite supplements, favorite health practices, and his changed view on intermittent fasting.

In this week's podcast Dr Arun Dhir, a gastroenterology surgeon, clinical researcher and author of Happy Gut, Healthy Weight, joins Dr Michelle Woolhouse as they delve into the crucial connection between gut health and various chronic conditions, including Gastro-oesophageal reflux disease (GORD) and its links with obesity. 1 in 5 people experience GORD on a weekly basis and in this episode, Dr Arun discusses his algorithm for investigating an individual presenting with GORD. Dr Arun also talks to the challenges of diagnosing conditions like hiatus hernias and the importance of comprehensive investigations, while offering practical advice on improving gut health through diet, stress management, and complementary therapies.  Covered in this episode: (0:46) Welcome Dr Arun Dhir  (2:30) Dr Arun's story  (7:25) “All diseases begin in the gut”  (12:16) Factors causing GORD  (18:17) Hiatus hernia  (21:39) Intra-abdominal pressure  (23:08) Helicobacter pylori  (25:35) Gut testing  (32:09) Gastrocolic reflex  (34:44) Complementary treatment options  (40:02) Low grade gastritis   (43:42) Final remarks  Find today's transcript and show notes here: https://www.bioceuticals.com.au/education/podcasts/gastro-oesophageal-reflux-disease---the-gut-microbiome-as-first-principle Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: www.bioceuticals.com.au/signup/ FX DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.

We're officially back for the 2025-26 Europa & Conference League campaigns, and as always, we're kicking things off with the 3rd qualifying rounds. The 1st legs were full of action, and we discuss some major upsets from old friends (Celje, Víkingur Reykjavík, AEK Larnaca), and new (Hibs, Shelbourne). Then we explore Cyrpus' remarkable European successes of late, why the Irish league is on the rise, if this is a breakout season for Scottish clubs, and speculate whether Malta is the next country to pop their cherry and qualify a team for European group stages for the very first time. We're also introduced to some clubs previously unfamiliar to us, including FC Polissya Zhytomyr, whose name we hopefully did not butchered to unreasonable degree. It feels good to be back – come hang! Cheers Joey O'Brien!

Podcast Summary This episode of the Pain Exam Podcast, hosted by Dr. David Rosenblum, discusses an interesting article about Ketorolac injections for musculoskeletal conditions. The podcast covers: Ketorolac is an NSAID that provides analgesic and anti-inflammatory effects through inhibition of prostaglandin synthesis Multiple studies comparing Ketorolac injections to corticosteroids and hyaluronic acid for various conditions Research shows Ketorolac injections are equally effective as corticosteroids for subacromial conditions, adhesive capsulitis, carpal-metacarpal joint issues, and hip/knee osteoarthritis Ketorolac may be a safer alternative to steroids for certain patients, though it has its own contraindications for those with renal, gastrointestinal, or cardiovascular disease Dr. Rosenblum considers the potential of using Ketorolac injections directly at pain sites rather than intramuscularly Upcoming Courses and Conferences Ultrasound courses in New York and Costa Rica (check unwrappedpain.org) Private ultrasound sessions available Dr. Rosenblum will be speaking at Pain Week about ultrasound in pain practice and PRP Presenting at a primary care conference in London Teaching ultrasound at ISPN LAPSES conference in Chile (Dr. Rosenblum won't attend this year) Ketorolac Injections: An Effective Alternative for Musculoskeletal Pain Management Musculoskeletal conditions such as bursitis, adhesive capsulitis, and osteoarthritis affect millions and often require injectable therapies to reduce pain and inflammation. Traditionally, corticosteroid injections have been the mainstay treatment. However, concerns over side effects like tendon rupture, cartilage damage, and systemic hyperglycemia have prompted exploration of alternatives. A recent narrative review by Kiel et al. (2024) highlights ketorolac—a parenteral nonsteroidal anti-inflammatory drug (NSAID)—as a promising substitute for corticosteroids in musculoskeletal injections. Warning: OFF Label use of Ketorolac discussed. Please consult your physician. See full article  for details. Subacromial Ketorolac Injections for Shoulder Pain Subacromial bursitis and impingement syndrome are common causes of shoulder pain and disability. Several randomized controlled trials have shown that subacromial ketorolac injections provide pain relief and functional improvement comparable to corticosteroids: Goyal et al. demonstrated significant reductions in pain scores after subacromial injection of 60 mg ketorolac versus 40 mg methylprednisolone, with no difference in outcomes between groups. Taheri et al. found similar short-term pain relief at 1 and 3 months with either ketorolac or corticosteroid subacromial injections. Kim et al. reported equivalent clinical improvement in rotator cuff syndrome patients receiving ketorolac or triamcinolone injections. Min et al. noted ketorolac led to better forward flexion and patient satisfaction at 4 weeks compared to corticosteroids. These studies support ketorolac as an effective agent for subacromial injection, offering an alternative for patients where corticosteroid use is limited. Intra-articular Ketorolac Injections for Adhesive Capsulitis and Osteoarthritis Adhesive capsulitis (frozen shoulder) and osteoarthritis of the hip, knee, and carpometacarpal joint are often treated with intra-articular corticosteroids. Ketorolac injections have shown comparable efficacy in these conditions: Akhtar et al. found intra-articular ketorolac significantly reduced shoulder pain at 4 weeks in adhesive capsulitis compared to hyaluronic acid. Ahn et al. reported similar pain relief between intra-articular ketorolac and corticosteroid injections in adhesive capsulitis, with ketorolac providing superior shoulder mobility at 3 and 6 months. Koh et al. showed that adding ketorolac to hyaluronic acid injections in carpometacarpal osteoarthritis resulted in faster onset of pain relief compared to hyaluronic acid alone. Park et al. observed equivalent functional improvements with intra-articular ketorolac or corticosteroids in hip osteoarthritis. Jurgensmeier et al. demonstrated similar symptom improvement at 1 and 3 months post-injection for ketorolac and triamcinolone in hip and knee osteoarthritis. Xu et al. and Bellamy et al. confirmed ketorolac's comparable pain relief and functional benefits to corticosteroids for knee osteoarthritis, with ketorolac being more cost-effective. Lee et al. noted quicker pain reduction with intra-articular ketorolac combined with hyaluronic acid versus hyaluronic acid alone in knee osteoarthritis. aSafety and Pharmacologic Considerations Ketorolac's anti-inflammatory action stems from cyclooxygenase inhibition, reducing prostaglandin synthesis. Its half-life is approximately 5.2–5.6 hours, and it is metabolized in the liver. Unlike corticosteroids, ketorolac avoids systemic hyperglycemia and cartilage damage risks. Animal and in vitro studies suggest ketorolac may protect cartilage by inhibiting inflammatory cytokines. While gastrointestinal, renal, and cardiovascular risks associated with NSAIDs remain considerations, localized intra-articular and subacromial ketorolac injections may limit systemic exposure and adverse effects. Mild, transient post-injection pain has been reported but resolves without intervention. Conclusion Ketorolac injections, administered intra-articularly or subacromially, are a safe, effective, and economical alternative to corticosteroids for managing common musculoskeletal conditions. Their comparable efficacy in reducing pain and improving function, combined with a more favorable side effect profile, makes ketorolac an appealing option for clinicians and patients alike. Further research is warranted to fully elucidate long-term safety and optimal dosing strategies. FAQS Ketorolac Injections for Musculoskeletal Conditions: Frequently Asked Questions Musculoskeletal pain from conditions like bursitis, adhesive capsulitis, and osteoarthritis often requires injectable treatments. Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is emerging as a promising alternative to corticosteroids. Below are common questions and answers based on a recent narrative review by Kiel et al. (2024). 1. What is ketorolac and how does it work? Ketorolac is a parenteral NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes, which decreases prostaglandin synthesis. It can be administered orally, intramuscularly, intravenously, or by injection directly into joints or around bursae. 2. How effective is ketorolac for musculoskeletal conditions? Studies show ketorolac injections provide significant pain relief and functional improvement comparable to corticosteroids in conditions like: Subacromial bursitis and shoulder impingement (subacromial injections) Adhesive capsulitis (frozen shoulder) (intra-articular injections) Osteoarthritis of the hip, knee, and thumb carpometacarpal joint (intra-articular injections) 3. What evidence supports subacromial ketorolac injections? Randomized controlled trials found: Goyal et al. and Taheri et al. reported similar pain reduction and functional outcomes between ketorolac and corticosteroids for subacromial injections. Kim et al. and Min et al. observed comparable or better patient satisfaction and shoulder mobility with ketorolac versus corticosteroids. 4. How does intra-articular ketorolac compare to corticosteroids for adhesive capsulitis? Akhtar et al. showed ketorolac reduced shoulder pain more than hyaluronic acid. Ahn et al. found ketorolac and corticosteroids equally effective for pain relief, with ketorolac providing better shoulder mobility at 3 and 6 months. 5. What about ketorolac for osteoarthritis? Ketorolac combined with hyaluronic acid provided faster pain relief than hyaluronic acid alone in thumb carpometacarpal joint osteoarthritis (Koh et al.). Intra-articular ketorolac had similar efficacy to corticosteroids in hip (Park et al., Jurgensmeier et al.) and knee osteoarthritis (Bellamy et al., Xu et al.). Ketorolac injections were more cost-effective compared to corticosteroids (Bellamy et al.). 6. Are ketorolac injections safe? Ketorolac's side effects are similar to other NSAIDs, mainly involving gastrointestinal, renal, and cardiovascular risks. However, localized intra-articular and subacromial injections may reduce systemic exposure. Animal studies suggest ketorolac does not harm cartilage and may protect against inflammatory damage. Mild, transient local pain post-injection is possible but usually resolves without treatment. 7. What are the limitations of ketorolac use? Ketorolac is not suitable for patients with: Renal impairment Gastrointestinal ulcers or bleeding risk Cardiovascular disease or hypertension NSAID hypersensitivity, especially in asthma or chronic urticaria patients Clinicians should assess individual risks before choosing ketorolac injections. 8. How does ketorolac's pharmacokinetics affect its use? Ketorolac has a plasma half-life of about 5.2 to 5.6 hours and is metabolized in the liver. Pharmacokinetics for subcutaneous or intra-articular administration are less defined but systemic absorption occurs. Its relatively short half-life supports repeated dosing if needed. 9. Why consider ketorolac over corticosteroids? Ketorolac avoids corticosteroid-associated risks such as tendon rupture, cartilage damage, and steroid-induced hyperglycemia. It is also more cost-effective, making it a favorable option for patients and healthcare systems. 10. What further research is needed? More large-scale, long-term studies are needed to fully understand ketorolac's intra-articular effects, optimal dosing, and safety profile compared to corticosteroids and other treatments. Summary: Ketorolac injections, whether intra-articular or subacromial, offer a safe, effective, and economical alternative to corticosteroids for managing various musculoskeletal conditions. This makes ketorolac an important option in pain management and inflammation control.     Reference: Kiel J, Applewhite AI, Bertasi TGO, Bertasi RAO, Seemann LL, Costa LMC, Helmi H, Pujalte GGA. Ketorolac Injections for Musculoskeletal Conditions: A Narrative Review. Clinical Medicine & Research. 2024;22(1):19-27. DOI: https://doi.org/10.3121/cmr.2024.1847 Disclaimer: This Podcast, website and any content from NRAP Academy (PMRexam.com) otherwise known as Qbazaar.com, LLC is  for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. Professionals should conduct their own fact finding, research, and due diligence to come to their own conclusions for treating patients. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.    

Podcast Summary This episode of the Pain Exam Podcast, hosted by Dr. David Rosenblum, discusses an interesting article about Ketorolac injections for musculoskeletal conditions. The podcast covers: Ketorolac is an NSAID that provides analgesic and anti-inflammatory effects through inhibition of prostaglandin synthesis Multiple studies comparing Ketorolac injections to corticosteroids and hyaluronic acid for various conditions Research shows Ketorolac injections are equally effective as corticosteroids for subacromial conditions, adhesive capsulitis, carpal-metacarpal joint issues, and hip/knee osteoarthritis Ketorolac may be a safer alternative to steroids for certain patients, though it has its own contraindications for those with renal, gastrointestinal, or cardiovascular disease Dr. Rosenblum considers the potential of using Ketorolac injections directly at pain sites rather than intramuscularly Upcoming Courses and Conferences Ultrasound courses in New York and Costa Rica (check unwrappedpain.org) Private ultrasound sessions available Dr. Rosenblum will be speaking at Pain Week about ultrasound in pain practice and PRP Presenting at a primary care conference in London Teaching ultrasound at ISPN LAPS  conference in Chile (Dr. Rosenblum won't attend this year) Ketorolac Injections: An Effective Alternative for Musculoskeletal Pain Management Musculoskeletal conditions such as bursitis, adhesive capsulitis, and osteoarthritis affect millions and often require injectable therapies to reduce pain and inflammation. Traditionally, corticosteroid injections have been the mainstay treatment. However, concerns over side effects like tendon rupture, cartilage damage, and systemic hyperglycemia have prompted exploration of alternatives. A recent narrative review by Kiel et al. (2024) highlights ketorolac—a parenteral nonsteroidal anti-inflammatory drug (NSAID)—as a promising substitute for corticosteroids in musculoskeletal injections. Warning: OFF Label use of Ketorolac discussed. Please consult your physician. See full article  for details. Subacromial Ketorolac Injections for Shoulder Pain Subacromial bursitis and impingement syndrome are common causes of shoulder pain and disability. Several randomized controlled trials have shown that subacromial ketorolac injections provide pain relief and functional improvement comparable to corticosteroids: Goyal et al. demonstrated significant reductions in pain scores after subacromial injection of 60 mg ketorolac versus 40 mg methylprednisolone, with no difference in outcomes between groups. Taheri et al. found similar short-term pain relief at 1 and 3 months with either ketorolac or corticosteroid subacromial injections. Kim et al. reported equivalent clinical improvement in rotator cuff syndrome patients receiving ketorolac or triamcinolone injections. Min et al. noted ketorolac led to better forward flexion and patient satisfaction at 4 weeks compared to corticosteroids. These studies support ketorolac as an effective agent for subacromial injection, offering an alternative for patients where corticosteroid use is limited. Intra-articular Ketorolac Injections for Adhesive Capsulitis and Osteoarthritis Adhesive capsulitis (frozen shoulder) and osteoarthritis of the hip, knee, and carpometacarpal joint are often treated with intra-articular corticosteroids. Ketorolac injections have shown comparable efficacy in these conditions: Akhtar et al. found intra-articular ketorolac significantly reduced shoulder pain at 4 weeks in adhesive capsulitis compared to hyaluronic acid. Ahn et al. reported similar pain relief between intra-articular ketorolac and corticosteroid injections in adhesive capsulitis, with ketorolac providing superior shoulder mobility at 3 and 6 months. Koh et al. showed that adding ketorolac to hyaluronic acid injections in carpometacarpal osteoarthritis resulted in faster onset of pain relief compared to hyaluronic acid alone. Park et al. observed equivalent functional improvements with intra-articular ketorolac or corticosteroids in hip osteoarthritis. Jurgensmeier et al. demonstrated similar symptom improvement at 1 and 3 months post-injection for ketorolac and triamcinolone in hip and knee osteoarthritis. Xu et al. and Bellamy et al. confirmed ketorolac's comparable pain relief and functional benefits to corticosteroids for knee osteoarthritis, with ketorolac being more cost-effective. Lee et al. noted quicker pain reduction with intra-articular ketorolac combined with hyaluronic acid versus hyaluronic acid alone in knee osteoarthritis. aSafety and Pharmacologic Considerations Ketorolac's anti-inflammatory action stems from cyclooxygenase inhibition, reducing prostaglandin synthesis. Its half-life is approximately 5.2–5.6 hours, and it is metabolized in the liver. Unlike corticosteroids, ketorolac avoids systemic hyperglycemia and cartilage damage risks. Animal and in vitro studies suggest ketorolac may protect cartilage by inhibiting inflammatory cytokines. While gastrointestinal, renal, and cardiovascular risks associated with NSAIDs remain considerations, localized intra-articular and subacromial ketorolac injections may limit systemic exposure and adverse effects. Mild, transient post-injection pain has been reported but resolves without intervention. Conclusion Ketorolac injections, administered intra-articularly or subacromially, are a safe, effective, and economical alternative to corticosteroids for managing common musculoskeletal conditions. Their comparable efficacy in reducing pain and improving function, combined with a more favorable side effect profile, makes ketorolac an appealing option for clinicians and patients alike. Further research is warranted to fully elucidate long-term safety and optimal dosing strategies. FAQS Ketorolac Injections for Musculoskeletal Conditions: Frequently Asked Questions Musculoskeletal pain from conditions like bursitis, adhesive capsulitis, and osteoarthritis often requires injectable treatments. Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is emerging as a promising alternative to corticosteroids. Below are common questions and answers based on a recent narrative review by Kiel et al. (2024). 1. What is ketorolac and how does it work? Ketorolac is a parenteral NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes, which decreases prostaglandin synthesis. It can be administered orally, intramuscularly, intravenously, or by injection directly into joints or around bursae. 2. How effective is ketorolac for musculoskeletal conditions? Studies show ketorolac injections provide significant pain relief and functional improvement comparable to corticosteroids in conditions like: Subacromial bursitis and shoulder impingement (subacromial injections) Adhesive capsulitis (frozen shoulder) (intra-articular injections) Osteoarthritis of the hip, knee, and thumb carpometacarpal joint (intra-articular injections) 3. What evidence supports subacromial ketorolac injections? Randomized controlled trials found: Goyal et al. and Taheri et al. reported similar pain reduction and functional outcomes between ketorolac and corticosteroids for subacromial injections. Kim et al. and Min et al. observed comparable or better patient satisfaction and shoulder mobility with ketorolac versus corticosteroids. 4. How does intra-articular ketorolac compare to corticosteroids for adhesive capsulitis? Akhtar et al. showed ketorolac reduced shoulder pain more than hyaluronic acid. Ahn et al. found ketorolac and corticosteroids equally effective for pain relief, with ketorolac providing better shoulder mobility at 3 and 6 months. 5. What about ketorolac for osteoarthritis? Ketorolac combined with hyaluronic acid provided faster pain relief than hyaluronic acid alone in thumb carpometacarpal joint osteoarthritis (Koh et al.). Intra-articular ketorolac had similar efficacy to corticosteroids in hip (Park et al., Jurgensmeier et al.) and knee osteoarthritis (Bellamy et al., Xu et al.). Ketorolac injections were more cost-effective compared to corticosteroids (Bellamy et al.). 6. Are ketorolac injections safe? Ketorolac's side effects are similar to other NSAIDs, mainly involving gastrointestinal, renal, and cardiovascular risks. However, localized intra-articular and subacromial injections may reduce systemic exposure. Animal studies suggest ketorolac does not harm cartilage and may protect against inflammatory damage. Mild, transient local pain post-injection is possible but usually resolves without treatment. 7. What are the limitations of ketorolac use? Ketorolac is not suitable for patients with: Renal impairment Gastrointestinal ulcers or bleeding risk Cardiovascular disease or hypertension NSAID hypersensitivity, especially in asthma or chronic urticaria patients Clinicians should assess individual risks before choosing ketorolac injections. 8. How does ketorolac's pharmacokinetics affect its use? Ketorolac has a plasma half-life of about 5.2 to 5.6 hours and is metabolized in the liver. Pharmacokinetics for subcutaneous or intra-articular administration are less defined but systemic absorption occurs. Its relatively short half-life supports repeated dosing if needed. 9. Why consider ketorolac over corticosteroids? Ketorolac avoids corticosteroid-associated risks such as tendon rupture, cartilage damage, and steroid-induced hyperglycemia. It is also more cost-effective, making it a favorable option for patients and healthcare systems. 10. What further research is needed? More large-scale, long-term studies are needed to fully understand ketorolac's intra-articular effects, optimal dosing, and safety profile compared to corticosteroids and other treatments. Summary: Ketorolac injections, whether intra-articular or subacromial, offer a safe, effective, and economical alternative to corticosteroids for managing various musculoskeletal conditions. This makes ketorolac an important option in pain management and inflammation control.     Reference: Kiel J, Applewhite AI, Bertasi TGO, Bertasi RAO, Seemann LL, Costa LMC, Helmi H, Pujalte GGA. Ketorolac Injections for Musculoskeletal Conditions: A Narrative Review. Clinical Medicine & Research. 2024;22(1):19-27. DOI: https://doi.org/10.3121/cmr.2024.1847 Disclaimer: This Podcast, website and any content from NRAP Academy (PMRexam.com) otherwise known as Qbazaar.com, LLC is  for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. Professionals should conduct their own fact finding, research, and due diligence to come to their own conclusions for treating patients. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.  

Podcast Summary This episode of the Pain Exam Podcast, hosted by Dr. David Rosenblum, discusses an interesting article about Ketorolac injections for musculoskeletal conditions. The podcast covers: Ketorolac is an NSAID that provides analgesic and anti-inflammatory effects through inhibition of prostaglandin synthesis Multiple studies comparing Ketorolac injections to corticosteroids and hyaluronic acid for various conditions Research shows Ketorolac injections are equally effective as corticosteroids for subacromial conditions, adhesive capsulitis, carpal-metacarpal joint issues, and hip/knee osteoarthritis Ketorolac may be a safer alternative to steroids for certain patients, though it has its own contraindications for those with renal, gastrointestinal, or cardiovascular disease Dr. Rosenblum considers the potential of using Ketorolac injections directly at pain sites rather than intramuscularly Upcoming Courses and Conferences Ultrasound courses in New York and Costa Rica (check unwrappedpain.org) Private ultrasound sessions available Dr. Rosenblum will be speaking at Pain Week about ultrasound in pain practice and PRP Presenting at a primary care conference in London Teaching ultrasound at ISPN LAPSES conference in Chile (Dr. Rosenblum won't attend this year) Ketorolac Injections: An Effective Alternative for Musculoskeletal Pain Management Musculoskeletal conditions such as bursitis, adhesive capsulitis, and osteoarthritis affect millions and often require injectable therapies to reduce pain and inflammation. Traditionally, corticosteroid injections have been the mainstay treatment. However, concerns over side effects like tendon rupture, cartilage damage, and systemic hyperglycemia have prompted exploration of alternatives. A recent narrative review by Kiel et al. (2024) highlights ketorolac—a parenteral nonsteroidal anti-inflammatory drug (NSAID)—as a promising substitute for corticosteroids in musculoskeletal injections. Warning: OFF Label use of Ketorolac discussed. Please consult your physician. See full article  for details. Subacromial Ketorolac Injections for Shoulder Pain Subacromial bursitis and impingement syndrome are common causes of shoulder pain and disability. Several randomized controlled trials have shown that subacromial ketorolac injections provide pain relief and functional improvement comparable to corticosteroids: Goyal et al. demonstrated significant reductions in pain scores after subacromial injection of 60 mg ketorolac versus 40 mg methylprednisolone, with no difference in outcomes between groups. Taheri et al. found similar short-term pain relief at 1 and 3 months with either ketorolac or corticosteroid subacromial injections. Kim et al. reported equivalent clinical improvement in rotator cuff syndrome patients receiving ketorolac or triamcinolone injections. Min et al. noted ketorolac led to better forward flexion and patient satisfaction at 4 weeks compared to corticosteroids. These studies support ketorolac as an effective agent for subacromial injection, offering an alternative for patients where corticosteroid use is limited. Intra-articular Ketorolac Injections for Adhesive Capsulitis and Osteoarthritis Adhesive capsulitis (frozen shoulder) and osteoarthritis of the hip, knee, and carpometacarpal joint are often treated with intra-articular corticosteroids. Ketorolac injections have shown comparable efficacy in these conditions: Akhtar et al. found intra-articular ketorolac significantly reduced shoulder pain at 4 weeks in adhesive capsulitis compared to hyaluronic acid. Ahn et al. reported similar pain relief between intra-articular ketorolac and corticosteroid injections in adhesive capsulitis, with ketorolac providing superior shoulder mobility at 3 and 6 months. Koh et al. showed that adding ketorolac to hyaluronic acid injections in carpometacarpal osteoarthritis resulted in faster onset of pain relief compared to hyaluronic acid alone. Park et al. observed equivalent functional improvements with intra-articular ketorolac or corticosteroids in hip osteoarthritis. Jurgensmeier et al. demonstrated similar symptom improvement at 1 and 3 months post-injection for ketorolac and triamcinolone in hip and knee osteoarthritis. Xu et al. and Bellamy et al. confirmed ketorolac's comparable pain relief and functional benefits to corticosteroids for knee osteoarthritis, with ketorolac being more cost-effective. Lee et al. noted quicker pain reduction with intra-articular ketorolac combined with hyaluronic acid versus hyaluronic acid alone in knee osteoarthritis. aSafety and Pharmacologic Considerations Ketorolac's anti-inflammatory action stems from cyclooxygenase inhibition, reducing prostaglandin synthesis. Its half-life is approximately 5.2–5.6 hours, and it is metabolized in the liver. Unlike corticosteroids, ketorolac avoids systemic hyperglycemia and cartilage damage risks. Animal and in vitro studies suggest ketorolac may protect cartilage by inhibiting inflammatory cytokines. While gastrointestinal, renal, and cardiovascular risks associated with NSAIDs remain considerations, localized intra-articular and subacromial ketorolac injections may limit systemic exposure and adverse effects. Mild, transient post-injection pain has been reported but resolves without intervention. Conclusion Ketorolac injections, administered intra-articularly or subacromially, are a safe, effective, and economical alternative to corticosteroids for managing common musculoskeletal conditions. Their comparable efficacy in reducing pain and improving function, combined with a more favorable side effect profile, makes ketorolac an appealing option for clinicians and patients alike. Further research is warranted to fully elucidate long-term safety and optimal dosing strategies. FAQS Ketorolac Injections for Musculoskeletal Conditions: Frequently Asked Questions Musculoskeletal pain from conditions like bursitis, adhesive capsulitis, and osteoarthritis often requires injectable treatments. Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is emerging as a promising alternative to corticosteroids. Below are common questions and answers based on a recent narrative review by Kiel et al. (2024). 1. What is ketorolac and how does it work? Ketorolac is a parenteral NSAID that reduces pain and inflammation by inhibiting cyclooxygenase enzymes, which decreases prostaglandin synthesis. It can be administered orally, intramuscularly, intravenously, or by injection directly into joints or around bursae. 2. How effective is ketorolac for musculoskeletal conditions? Studies show ketorolac injections provide significant pain relief and functional improvement comparable to corticosteroids in conditions like: Subacromial bursitis and shoulder impingement (subacromial injections) Adhesive capsulitis (frozen shoulder) (intra-articular injections) Osteoarthritis of the hip, knee, and thumb carpometacarpal joint (intra-articular injections) 3. What evidence supports subacromial ketorolac injections? Randomized controlled trials found: Goyal et al. and Taheri et al. reported similar pain reduction and functional outcomes between ketorolac and corticosteroids for subacromial injections. Kim et al. and Min et al. observed comparable or better patient satisfaction and shoulder mobility with ketorolac versus corticosteroids. 4. How does intra-articular ketorolac compare to corticosteroids for adhesive capsulitis? Akhtar et al. showed ketorolac reduced shoulder pain more than hyaluronic acid. Ahn et al. found ketorolac and corticosteroids equally effective for pain relief, with ketorolac providing better shoulder mobility at 3 and 6 months. 5. What about ketorolac for osteoarthritis? Ketorolac combined with hyaluronic acid provided faster pain relief than hyaluronic acid alone in thumb carpometacarpal joint osteoarthritis (Koh et al.). Intra-articular ketorolac had similar efficacy to corticosteroids in hip (Park et al., Jurgensmeier et al.) and knee osteoarthritis (Bellamy et al., Xu et al.). Ketorolac injections were more cost-effective compared to corticosteroids (Bellamy et al.). 6. Are ketorolac injections safe? Ketorolac's side effects are similar to other NSAIDs, mainly involving gastrointestinal, renal, and cardiovascular risks. However, localized intra-articular and subacromial injections may reduce systemic exposure. Animal studies suggest ketorolac does not harm cartilage and may protect against inflammatory damage. Mild, transient local pain post-injection is possible but usually resolves without treatment. 7. What are the limitations of ketorolac use? Ketorolac is not suitable for patients with: Renal impairment Gastrointestinal ulcers or bleeding risk Cardiovascular disease or hypertension NSAID hypersensitivity, especially in asthma or chronic urticaria patients Clinicians should assess individual risks before choosing ketorolac injections. 8. How does ketorolac's pharmacokinetics affect its use? Ketorolac has a plasma half-life of about 5.2 to 5.6 hours and is metabolized in the liver. Pharmacokinetics for subcutaneous or intra-articular administration are less defined but systemic absorption occurs. Its relatively short half-life supports repeated dosing if needed. 9. Why consider ketorolac over corticosteroids? Ketorolac avoids corticosteroid-associated risks such as tendon rupture, cartilage damage, and steroid-induced hyperglycemia. It is also more cost-effective, making it a favorable option for patients and healthcare systems. 10. What further research is needed? More large-scale, long-term studies are needed to fully understand ketorolac's intra-articular effects, optimal dosing, and safety profile compared to corticosteroids and other treatments. Summary: Ketorolac injections, whether intra-articular or subacromial, offer a safe, effective, and economical alternative to corticosteroids for managing various musculoskeletal conditions. This makes ketorolac an important option in pain management and inflammation control.     Reference: Kiel J, Applewhite AI, Bertasi TGO, Bertasi RAO, Seemann LL, Costa LMC, Helmi H, Pujalte GGA. Ketorolac Injections for Musculoskeletal Conditions: A Narrative Review. Clinical Medicine & Research. 2024;22(1):19-27. DOI: https://doi.org/10.3121/cmr.2024.1847 Disclaimer: This Podcast, website and any content from NRAP Academy (PMRexam.com) otherwise known as Qbazaar.com, LLC is  for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. Professionals should conduct their own fact finding, research, and due diligence to come to their own conclusions for treating patients. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.    

South Korea’s president, Lee Jae Myung, orders the removal of loudspeakers to reduce tension with Pyongyang. Plus: Witkoff in Moscow, luxury earnings takeaways and a musical round-up with Matt Wolf. See omnystudio.com/listener for privacy information.

Canada Immigration LMIA-Exempt Work Permit figures for C61,  (Intra-company transferees starting a branch or affiliate in Canada) in  2023, for Total visas issued by IRCC.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration Practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario  In 2023, a total of  245 LMIA-Exempt Work Permits were issued by IRCC, under C61, (Intra-company transferees starting a branch or affiliate in Canada) If you have an interest in gaining assistance with Work Permits based on your country of Citizenship, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant 

 Canada Immigration LMIA-Exempt Work Permit figures for C61, (Intra-company transferees starting a branch or affiliate in Canada) in 2023 for the province/territory of Alberta.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario  The Province or Territory of Alberta accepted 10 LMIA-Exempt Work Permits in 2023, under C61, (Intra-company transferees starting a branch or affiliate in Canada).Stay informed about past events in Alberta by visiting this link: https://myar.me/tag/ab If you are interested in gaining comprehensive insights into the Federal Canadian Experience Class or other Canadian Federal or Provincial Immigration programs, or if you need guidance post-selection, we cordially invite you to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly request you to thoroughly review the available resources. Subsequently, if you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session on Fridays. You can find details for both these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant 

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of Ontario. Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Ontario accepted 340 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility).Dive into the archives of news from the Province of Ontario through this link: https://myar.me/tag/onIf you are interested in gaining comprehensive insights into the Quebec Investor Program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we warmly invite you to connect with us via https://myar.me/c. We strongly encourage you to participate in our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully review the available resources. If you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session on Fridays. You can find details for both meetings at https://myar.me/zoom. Our dedicated team is committed to offering professional assistance throughout your immigration journey. In addition, IRCNews provides valuable insights on selecting a qualified representative to advocate for you with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in  2023, for Total visas issued by IRCC.Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario  In 2023, a total of 1320 LMIA-Exempt Work Permits were issued by IRCC, under C16, (Intra-Company Transferee Francophone mobility).  If you have an interest in gaining assistance with Work Permits based on your country of Citizenship, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant 

Canada Immigration LMIA-Exempt Work Permit figures for C16,  (Intra-Company Transferee Francophone mobility) in  2022, for Total visas issued by IRCC.Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario  In 2022, a total of  875 LMIA-Exempt Work Permits were issued by IRCC, under C16, (Intra-Company Transferee Francophone mobility).   If you have an interest in gaining assistance with Work Permits based on your country of Citizenship, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of Saskatchewan. Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Saskatchewan accepted 15 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility).Discover past news items from Saskatchewan by clicking on this link: https://myar.me/tag/skShould you be interested in gaining comprehensive insights into the Federal Atlantic Immigration Program (AIP) or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we warmly invite you to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully review the available resources. In case you have any inquiries, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can access details for both of these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.

Canada Immigration LMIA-Exempt Work Permit figures for C16,  (Intra-Company Transferee Francophone mobility) in  2021, for Total visas issued by IRCC.Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario  In 2021, a total of  235 LMIA-Exempt Work Permits were issued by IRCC, under C16, (Intra-Company Transferee Francophone mobility).   If you have an interest in gaining assistance with Work Permits based on your country of Citizenship, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of Quebec.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Quebec accepted 5 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility) Access archived news articles from Quebec via this link: https://myar.me/tag/qcIf you are interested in gaining comprehensive insights into the Federal Startup Business Program or other Canadian Federal or Provincial Immigration programs, or if you need guidance post-selection, we cordially invite you to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly request you to thoroughly review the available resources. Subsequently, if you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session on Fridays. You can find details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of Prince Edward Island.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Prince Edward Island accepted 20 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility)Keep up with previous news stories from Prince Edward Island through this link: https://myar.me/tag/pe Should you be interested in acquiring comprehensive insights into the Canadian Federal Parents & Grandparents sponsorship program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly encourage your participation in our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully examine the available resources. In case you have any inquiries, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session conducted on Fridays. You can access details for both of these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing professional assistance as you navigate the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate for you with the Canadian Federal or Provincial governments, available at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2023 for the province/territory of British Columbia.   Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of British Columbia accepted 235 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility s).To delve into the history of news in British Columbia, follow this link: https://myar.me/tag/bcIf you have an interest in gaining comprehensive insights into the Canadian Federal Spouses and Partners sponsorship program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of Manitoba.   Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Manitoba accepted 60 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility).To delve into the history of news in Manitoba, follow this link: https://myar.me/tag/mbIf you have an interest in gaining comprehensive insights into the Canadian Federal Spouses and Partners sponsorship program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant. 

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of New Brunswick.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of New Brunswick accepted 265 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility).Stay updated with past news in New Brunswick by visiting this link: https://myar.me/tag/nb/. If you have an interest in acquiring comprehensive insights into the Federal RNIP or Rural and Northern Immigration Pilot program or other Canadian Federal or Provincial Immigration programs, or if you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We highly recommend your attendance at our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Should any queries arise subsequently, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance throughout your immigration process. In addition, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2023 for the province/territory of Northwest Territories.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Northwest Territories accepted 10 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility s).Explore past news stories from North West Territories using the following link: https://myar.me/tag/nt If you have an interest in gaining comprehensive insights into the Federal Self Employed program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant. 

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2023 for the province/territory of Nova Scotia.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Nova Scotia accepted 25 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility).If you wish to review past news from Nova Scotia, this link will guide you: https://myar.me/tag/nsShould you have an interest in gaining comprehensive insights into the Federal Skills Trade Canadian Express Entry Program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we warmly invite you to connect with us via https://myar.me/c. We strongly encourage participation in our complimentary Zoom resource meetings conducted every Thursday. We kindly ask you to diligently peruse the available resources. In case you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can access details for both of these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing professional assistance as you navigate the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, available at https://ircnews.ca/consultant.

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Ontario.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Ontario accepted 275 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).Dive into the archives of news from the Province of Ontario through this link: https://myar.me/tag/on/.If you are interested in gaining comprehensive insights into the Quebec Investor Program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we warmly invite you to connect with us via https://myar.me/c. We strongly encourage you to participate in our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully review the available resources. If you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session on Fridays. You can find details for both meetings at https://myar.me/zoom. Our dedicated team is committed to offering professional assistance throughout your immigration journey. In addition, IRCNews provides valuable insights on selecting a qualified representative to advocate for you with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Quebec.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Quebec accepted 5 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).Access archived news articles from Quebec via this link: https://myar.me/tag/qc If you are interested in gaining comprehensive insights into the Federal Startup Business Program or other Canadian Federal or Provincial Immigration programs, or if you need guidance post-selection, we cordially invite you to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly request you to thoroughly review the available resources. Subsequently, if you have any questions, our team of Canadian Authorized Representatives is readily available to address yours concerns during the weekly AR's Q&A session on Fridays. You can find details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Prince Edward Island.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Prince Edward Island accepted 15 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).Keep up with previous news stories from Prince Edward Island through this link: https://myar.me/tag/pe Should you be interested in acquiring comprehensive insights into the Canadian Federal Parents & Grandparents sponsorship program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly encourage your participation in our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully examine the available resources. In case you have any inquiries, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session conducted on Fridays. You can access details for both of these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing professional assistance as you navigate the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate for you with the Canadian Federal or Provincial governments, available at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2023 for the province/territory of Alberta.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario The Province or Territory of Alberta accepted 330 LMIA-Exempt Work Permits in 2023, under C16, (Intra-Company Transferee Francophone mobility s).Stay informed about past events in Alberta by visiting this link: https://myar.me/tag/ab If you are interested in gaining comprehensive insights into the Federal Canadian Experience Class or other Canadian Federal or Provincial Immigration programs, or if you need guidance post-selection, we cordially invite you to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly request you to thoroughly review the available resources. Subsequently, if you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session on Fridays. You can find details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Yukon.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario The Province or Territory of Yukon accepted 10 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s). For a convenient way to check past news in Yukon Territory, just visit this link: https://myar.me/tag/ytShould you be interested in acquiring comprehensive insights into the Federal Caring for Children Program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly encourage your participation in our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully examine the available resources. In case you have any inquiries, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session conducted on Fridays. You can access details for both of these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance as you navigate the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate for you with the Canadian Federal or Provincial governments, available at https://ircnews.ca/consultant. 

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Saskatchewan.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Saskatchewan accepted 10 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility)Discover past news items from Saskatchewan by clicking on this link: https://myar.me/tag/sk Should you be interested in gaining comprehensive insights into the Federal Atlantic Immigration Program (AIP) or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we warmly invite you to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly ask you to carefully review the available resources. In case you have any inquiries, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can access details for both of these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant. 

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Nova Scotia. Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Nova Scotia accepted 20 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).If you wish to review past news from Nova Scotia, this link will guide you: https://myar.me/tag/nsShould you have an interest in gaining comprehensive insights into the Federal Skills Trade Canadian Express Entry Program or other Canadian Federal or Provincial Immigration programs, or if you require guidance after selection, we warmly invite you to connect with us via https://myar.me/c. We strongly encourage participation in our complimentary Zoom resource meetings conducted every Thursday. We kindly ask you to diligently peruse the available resources. In case you have any questions, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can access details for both of these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance as you navigate the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, available at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of British Columbia.Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario The Province or Territory of British Columbia accepted 215 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s). To delve into the history of news in British Columbia, follow this link: https://myar.me/tag/bc  If you have an interest in gaining comprehensive insights into the Canadian Federal Spouses and Partners sponsorship program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c.  We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.  

 Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility) in 2022 for the province/territory of Alberta Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario   The Province or Territory of Alberta accepted 180 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s). To delve into the history of news in British Columbia, follow this link: https://myar.me/tag/ab If you have an interest in gaining comprehensive insights into the Canadian Federal Spouses and Partners sponsorship program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c.  We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.   

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Northwest Territories. Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, OntarioThe Province or Territory of Northwest Territories accepted 5 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).Explore past news stories from North West Territories using the following link: https://myar.me/tag/nt  If you have an interest in gaining comprehensive insights into the Federal Self Employed program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c.  We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom.  Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Newfoundland and Labrador. Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario The Province or Territory of Newfoundland and Labrador accepted 95 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).You have the option to browse through historical news from Newfoundland by clicking this link: https://myar.me/tag/nl/. Should you be interested in gaining comprehensive insights into the Quebec Skilled Program or other Canadian Federal or Provincial Immigration programs, or if you find yourself in need of guidance after selection, we extend a warm invitation to connect with us via https://myar.me/c. We highly recommend attending our complimentary Zoom resource meetings held every Thursday. We kindly request you to carefully review the available resources. In case you have any inquiries, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can access details for both of these meetings at https://myar.me/zoom.Our dedicated team is committed to providing professional assistance throughout your immigration journey. Furthermore, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant. 

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of New Brunswick.Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario The Province or Territory of New Brunswick accepted 95 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).Stay updated with past news in New Brunswick by visiting this link: https://myar.me/tag/nb/. If you have an interest in acquiring comprehensive insights into the Federal RNIP or Rural and Northern Immigration Pilot program or other Canadian Federal or Provincial Immigration programs, or if you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We highly recommend your attendance at our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Should any queries arise subsequently, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing professional assistance throughout your immigration process. In addition, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.  

Canada Immigration LMIA-Exempt Work Permit figures for C16, (Intra-Company Transferee Francophone mobility s) in 2022 for the province/territory of Manitoba.  Good day ladies and gentlemen, this is IRC news, and I am Joy Stephen, an authorized Canadian Immigration practitioner bringing out this Canada Work Permit application data specific to LMIA work permits or employer driven work permits or LMIA exempt work permits for multiple years based on your country of Citizenship. I am coming to you from the Polinsys studios in Cambridge, Ontario The Province or Territory of Manitoba accepted 20 LMIA-Exempt Work Permits in 2022, under C16, (Intra-Company Transferee Francophone mobility s).To delve into the history of news in Manitoba, follow this link: https://myar.me/tag/mb If you have an interest in gaining comprehensive insights into the Canadian Federal Spouses and Partners sponsorship program or other Canadian Federal or Provincial Immigration programs, or should you require guidance post-selection, we extend a warm invitation to connect with us via https://myar.me/c. We strongly recommend attending our complimentary Zoom resource meetings conducted every Thursday. We kindly request you to carefully review the available resources. Subsequently, should any queries arise, our team of Canadian Authorized Representatives is readily available to address your concerns during the weekly AR's Q&A session held on Fridays. You can find the details for both these meetings at https://myar.me/zoom. Our dedicated team is committed to providing you with professional assistance in navigating the immigration process. Additionally, IRCNews offers valuable insights on selecting a qualified representative to advocate on your behalf with the Canadian Federal or Provincial governments, accessible at https://ircnews.ca/consultant.   

In this episode of The Litigation Psychology Podcast, Bill Kanasky, Jr., Ph.D. dives into the rapidly evolving world of plaintiff attorney advertising and specifically how it's exploded on social media. While traditional ads like billboards and cheesy daytime TV spots are still around, many plaintiff firms are now taking a totally different approach online. Bill explains how these firms are using TikTok, Instagram, and X (formally Twitter) to push out videos that aren't focused on big verdicts or settlements, but rather aimed at shaping public opinion and, ultimately, juror attitudes. Bill breaks these videos down into five key themes: 1. Anti-insurance messaging, where attorneys warn viewers not to speak with or accept offers from insurance companies because “they'll screw you”; 2. Humanization of the plaintiff firm, posting behind-the-scenes office tours, staff intros, and even lighthearted content like dance videos and trivia to show they're just regular, likable people; 3. Educational content, where attorneys explain litigation terms and legal processes in simple, friendly language; 4. Do's and don'ts videos, like checklists for what to do if you're injured or filing a claim; 5. Intra-plaintiff firm competition, where attorneys differentiate themselves by claiming superior trial skills over “billboard lawyers.” Bill notes that what's most interesting is that these videos and messages are rarely about huge payouts but instead they're about fairness, trust, and credibility. And it's working. Plaintiff attorneys continue to build successful practices and jurors see these videos, and consciously or not, they come into the courtroom with biases that can be hard to shake. Bill points out that the defense bar and insurance industry are completely missing from this space, leaving the messaging one-sided. Lastly, Bill asks the questions: should the defense start countering this? And should voir dire include questions about social media exposure to these types of messages? 

Fasted training? GI issues during training? Not sure about how to eat around workouts? Krissy, Amanda, and Ryann break down how to fuel before, during, and after training so you can train harder, recover faster, and actually perform the way you're trying to. No fluff or clean eating dogma, just dialed-in just strategies to help you show up better in every session and stop sabotaging your own progress. Black Iron NutritionBook a Free Discovery CallFree Macro CalculatorFree DownloadsBlack Iron BlogCheck Out Fe26Strategy Session

Lisa Carlin, Sandra Herrera, and Aaron West recap TST as two members of Attacking Third faced off in the final. Then, the group explain both Intra-League Loans in the NWSL and the Building Assets that expansion sides Boston and Denver will receive for their inaugural season in 2026. And finally, the A3 Mailbag is opened once again to answer your questions. Watch USWNT and NWSL games on P+" with a link to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.paramountplus.com/home/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Attacking Third is available for free on the Audacy app as well as Apple Podcasts, Spotify, Google Podcasts, Stitcher and wherever else you listen to podcasts.  Follow the Attacking Third team on Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@AttackingThird⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@LisaCarlin32⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@SandHerrera_⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@Darian_Jenks⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@CCupo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Visit the Attacking Third YouTube channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/attackingthird⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ You can listen to Attacking Third on your smart speakers! Simply say "Alexa, play the latest episode of the Attacking Third podcast" or "Hey Google, play the latest episode of the Attacking Third podcast." To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Welcome to Season 2 of the Orthobullets Podcast. Today's show is Coinflips, where expert speakers discuss grey zone decisions in orthopedic surgery. This episode will feature doctors Damayea Hargett, Emily Benson, John Scolaro, & Charles Moon. They will discuss the case titled "⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Open Segmental Femur Fx with Distal Intra-articular Extension in 25M⁠⁠⁠.⁠⁠⁠⁠⁠⁠" Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Linkedln⁠

In this episode Derek Champagne talks with Shark Tank veteran Yannis Moati. Yannis is the Founder & CEO of Hotels by Day, which seamlessly unlocks latent intra-day room inventory, bringing guests the flexibility of short stays. Intra-day rooms being the inventory of unsold rooms from the night before pooled with early checkouts.Yannis shares his experiences launching his new business and growing his national brand.Learn more at www.hotelsbyday.com

Two governors walk into the Reagan Library and find common ground. Steve Hayes is joined by Utah Governor Spencer Cox (R) and New Mexico Governor Michelle Lujan Grisham (D), to discuss bipartisanship, mutual respect, and the value of healthy conflict. The Agenda:—Defining tribes—Media outrage and news cycles—We should all join bowling teams—We can't explain policy in 280 characters—Intra-party tensions Learn more about your ad choices. Visit megaphone.fm/adchoices